AdvaMed Calls For Less Complicated CMS Blood Billing Procedures
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed, prompted by a group of member companies, is working with the American Association of Blood Banks to promote proper hospital billing of blood products and services in an attempt to improve the claims data used to set Medicare reimbursement rates
You may also be interested in...
CMS Blood Billing Rules Lead To Inadequate Reimbursement – Lewin Report
Updated guidelines on properly billing CMS for blood products and services will soon be available to hospitals from the American Association of Blood Banks, the industry group announced Oct. 15
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.